Go Back

Company or ticker...

Edgewise Therapeutics

Edgewise develops muscle-targeted medicines for muscular dystrophies and heart disease.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

EWTX

4.5B

0.0

n/a

65.31%

Key Facts

M. Cap

PS

PE

YTD

4.5B

0.0

n/a

65.31%

10MA

20MA

50MA

200MA

$EWTX

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now